Research is indicating a shift in understanding tumor evolution, moving from a focus on morphology to functional networks. This shift may lead to advancements in precision diagnosis and treatment for various types of cancer, including lung, colorectal, and breast cancer. The integration of artificial intelligence and molecular pathology is being explored as a means to improve clinical applications and therapy.